Mind Medicine (STU:MMQ) Other Long Term Assets : €0.56 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine Other Long Term Assets?

Mind Medicine's other long-term assets for the quarter that ended in Mar. 2025 was €0.56 Mil.

Mind Medicine's quarterly other long-term assets increased from Sep. 2024 (€0.44 Mil) to Dec. 2024 (€0.58 Mil) but then stayed the same from Dec. 2024 (€0.58 Mil) to Mar. 2025 (€0.56 Mil).

Mind Medicine's annual other long-term assets declined from Dec. 2022 (€0.31 Mil) to Dec. 2023 (€0.20 Mil) but then increased from Dec. 2023 (€0.20 Mil) to Dec. 2024 (€0.58 Mil).

Mind Medicine Other Long Term Assets Historical Data

The historical data trend for Mind Medicine's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Other Long Term Assets Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

0.31

0.20

0.58

Mind Medicine Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															0.13	0.50	0.44	0.58	0.56

Mind Medicine Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Mind Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (STU:MMQ) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMQ:Germany

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Mind Medicine Headlines

No Headlines